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Abstract
Background: Genetic polymophisms of the Duffy antigen receptor for the chemokines (DARC) gene successfully
protected against blood stage infection by Plasmodium vivax infection. The Fy (a-, b-) phenotype is predominant
among African populations, particularly those originating from West Africa, and it is rare among non-African
populations. The aim of this study was to analyse the frequency of four Duffy blood groups based on SNPs (T-33C,
G125A, G298A and C5411T) in two local tribes of Sudanese Arabs, the Shagia and Manasir, which are both from
the region of the Fourth Nile cataract in Sudan.
Methods: An analysis of polymorphisms was performed on 217 individuals (126 representatives of the Shagia tribe
and 91 of the Manasir). Real-time PCR and TaqMan Genotyping Assays were used to study the prevalence of alleles
and genotypes.
Results: The analysis of allelic and genotype frequency in the T-33C polymorphisms demonstrated a significant
dominance of the C allele and CC genotype (OR = 0.53 [0.32-0.88]; p = 0.02) in both tribes. The G125A polymorphism
is associated with phenotype Fy(a-, b-) and was identified in 83% of Shagia and 77% of Manasir. With regard to
G298A polymorphisms, the genotype frequencies were different between the tribes (p = 0,002) and no single AA
homozygote was found. Based on four SNPs examined, 20 combinations of genotypes for the Shagia and Manasir
tribes were determined. The genotype CC/AA/GG/CT occurred most often in Shagia tribe (45.9%) but was rare in the
Manasir tribe (6.6%) (p < 0.001 Shagia versus Manasir). The FY*A
ES allele was identified in both analysed tribes. The
presence of individuals with the FY*A/FY*A genotype was demonstrated only in the Shagia tribe.
Conclusion: This is probably the first report showing genotypically Duffy-negative people who carry both FY*B
ES
and FY*A
ES. The identification of the FY*A
ES allele in both tribes may be due to admixture of the non-African
genetic background. Taken as a whole, allele and genotype frequencies between the Shagia and the Manasir were
statistically different. However, the presence of individuals with the FY*A/FY*A genotype was demonstrated only in
the Shagia tribe.
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Background
Africa is considered as the origin of modern humans and
is one of the most ethnically and genetically diverse
regions of the world [1]. The African populations were
shaped by demographic forces that influence variation on
a genome-wide scale, such as ancient migration events
and fluctuations in population size, and by evolutionary
forces that influence individual loci, such as natural selec-
tion and mutation [2]. A great impact on human evolution
is associated with malaria, one of the most significant
infectious diseases in the world [3]. Selection pressure by
this pathogen on the human genome occurred at least
10,000 years ago. It has been generally recognized that
malaria was one of the factors determining population
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bin, such as haemoglobin S (HbS), C (HBC) or E (HBE), as
well as variability in the Duffy blood group system.
The Duffy antigen is located on the surface of red
blood cells. Duffy antigens are coded on the Duffy anti-
gen receptor for the chemokine gene (DARC), located on
the long arm of chromosome 1 (1.q22-1.q23) [4]. The
protein encoded by this gene is a glycosylated membrane
protein, which is a non-specific receptor for several che-
mokines and can be utilized by human malarial parasites
Plasmodium vivax and Plasmodium knowlesi in order to
invade erythrocytes.
Genetic polymorphisms were identified in humans,
which affect the expression of the Duffy antigen. Duffy
antigen is present in two major allelic forms, differing in
an amino acid at position 42 in coding sequence (G125A)
(i.e. glycine in FY*A and aspartic acid in FY*B) [5-9] and
point mutation at position T-33°C (previously described
as T-46°C) in GATA box responsible for the FY*A
ES
(ES = erythrocyte silent) and the FY*B
ES alleles (common
African allele) [3,10-16]. These four alleles: FY*A, FY*B,
FY*A
ES and FY*B
ES contribute to a total of ten genotypes:
FY*A/FY*A, FY*A/FY*B, FY*A/FY*A
ES,F Y * A / F Y * B
ES,
FY*B/FY*B, FY*B/FY*A
ES,F Y * B / F Y * B
ES,F Y * A
ES/FY*A
ES,
FY*A
ES/FY*B
ES,F Y * B
ES/FY*B
ES [17,18]. The last three
genotypes of those above-mentioned are responsible for
the phenotype Fy(a-, b-) which is responsible for resis-
tance to malaria. This phenotype is predominant among
African people, especially those originating in West
Africa and it is rare among non-African populations [11].
This lack of DARC receptors among almost all indivi-
duals of West African origin has been suggested as a nat-
ural selection induced by P. vivax [19]. Moreover, a less
common variation of the allele FY*X, associated with
weak expression of Fy
b antigen was also identified
[8,10,20].
Due to the characteristic distribution of DARC alleles:
FY*A
ES and FY*B
ES, they have been used to assess admix-
ture and ethnic backgrounds of populations like Saudi
Arabs [21], Israeli Jews [22,23], Grande Comore Island
islanders (Njazidja) [24] and also some African descent
populations [25]. Characterizing the pattern of genetic
variation among ethnically diverse African populations is
critical for reconstructing human evolutionary history,
clarifying the population history of Africans and African-
Americans and determining the proper design and inter-
pretation of genetic disease association studies [26,27].
Genetic variation of many populations across Africa is
enigmatic [28]. There are some very uncommon and
unique African tribes that are not well genetically charac-
terized. Current demographic and political situations in
Africa make any anthropological research conducted in
this area very valuable. The Shagia tribe, until recently,
inhabited the area from the Kurti to the Fourth Cataract.
This tribe led an agricultural lifestyle and was regarded
as morally and culturally governed by the Sudanese
Arabs. The village populations were not numerous (40-
60 persons per village) and were located at small
distances from each other in difficult to access areas.
Residents were isolated geographically and culturally,
which led to genetic isolation. Recently, the natural resi-
dence of this tribe has been changed due to the construc-
tion of dams in the Merowe at the height of the Fourth
Cataract of the Nile river (Sudan), which required mas-
sive displacement and dispersion of the Shagia tribe. For
that reason the presented study is exclusive and irre-
placeable. The second tribe examined, the Manasir, lives
approximately 80 km from the described Shagia villages
and represents a population with admixture of other
populations. Approximately 50,000-78,000 people
(including the ethnically related Shagia and Manasir
tribes) have been displaced to the settlements built in the
Nubian Desert. Despite the undoubted benefits of the
construction of new hydroelectric plants, such as univer-
sal access to electricity, there are far-reaching conse-
quences for the environment and human health (e.g., the
development of diseases, such as Snail fever).
T h ep u r p o s eo ft h i ss t u d yw a st oa n a l y s et h eg e n e t i c
structure of the Shagia and Manasir tribes using the
variability of the single nucleotide polymorphisms in
Duffy gene, such as two typical for African populations
SNPs: T-33 C [5,29] and G125A [14,30], along with two
other SNPs: G298A [31-33] and C5411T.
The distinction of the Shagia tribe is one of the rea-
sons why the prevalence of gene polymorphisms in the
FY (Duffy) is very interesting. The results obtained in
this study, based on the biological samples collected
before the tribe dislocation, may be helpful in determin-
ing the origin of this tribe and enriching the existing
knowledge on population movements in the African
continent.
Methods
Subjects
An analysis of polymorphisms was performed on 217
individuals (101 females and 116 males; median age 30
years). Genetic material (buccal swabs) was collected
from 126 individuals of the Shagia tribe and from 91
representatives of the Manasir that consented to partici-
pate in the study. Both tribes inhabited the Fourth Cat-
aract of the Nile at the time of the study.
The authors state their research conforms to the Hel-
sinki Declaration and to local legislation. Informed con-
sent from patients was a prerequisite. Institutional
ethical clearance from the Ethic Committee of Pomera-
nian Medical University was obtained.
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Buccal swabs for subsequent DNA extraction were col-
lected from all individuals that consented to participate in
the study. Collected swabs were carefully dried in a sepa-
rate area in order to avoid contamination. For DNA
extraction, a BuccalAmp DNA Extraction Kit (Epicentre,
Madison, USA) was used. Oligonucleotide primers and
TaqMan probes for Duffy polymorphisms (i.e. Rs2814778,
Rs12075, Rs13962 and Rs863002) were designed and
synthesized by Applied Biosystems (ID: C__15769614_10,
C__2493442_10, C__2493443_10, C__7480790_10, respec-
tively). The fluorescence data were analysed with allelic
discrimination 7500 Software, v.2.0.2.
Statistical analysis
Statistical analyses were performed with the StatView
®
program using the chi
2 Pearsons, Fisher test. Haplotype
analysis using haplo.stats [34] package was made by R
software, version 2.10.1. The validation of haplotypes and
a linkage disequilibrium (LD) block of polymorphisms
were performed using Haploview, version 4.02. P < 0 0.05
was considered statistically significant.
Results
The identification of genes encoding the blood group anti-
gens, such as DARC, has been used for many years to
assess population admixture and ethnic backgrounds.
Duffy polymorphisms are characterized for African popu-
lations, therefore identification of the FyB
ES variant in
non-African populations is likely to be the result of admix-
ture of the African-American genetic background
[6,11,35]. The genotype and allele frequency distributions
recorded for four analysed SNPs in two population groups,
the Shagia and Manasir tribes, are presented in Table 1.
Genotype distributions were consistent with the Hardy-
Weinberg expectations for T-33 C and G125A SNPs only
(Table 1).
Pair-wise linkage disequilibrium (LD) between T-33 C
and G125A polymorphisms was calculated using the
normalized disequilibrium coefficient (D’) and was equal
0.51 (Corr = 0,31, p = 5e
-10).
The analysis of allelic and genotype frequency in the T-
33 C polymorphisms demonstrated a significant domi-
nance of the C allele and CC genotype (OR = 0.53 [0.32-
0.88]) in both tribes. Moreover, the frequency of allele C
was significantly higher in Shagia than Manasir (p =
0.02). The prevalence of CC genotype in the Shagia and
the Mansir was respectively 77% and 62.6%. These results
are in agreement with previous reports showing that the
-33 C allele was present in 79% of South African blacks
[25] and 78.3% of African-American populations [30].
Allelic and genotype frequencies in other analysed SNPs,
i.e. G125A and C5411T were similar in both tribes and
align with the data representative for Africans. The study
showed that AA homozygotes are dominant in G125A
polymorphisms among the members of Shagia and
Manasir tribes (88.9% and 86.8%, respectively). With
regard to G298A polymorphisms the genotype frequen-
cies were different between the tribes (p = 0,002). It is
worthy of note that no single AA homozygote was found
in the examined groups although the presence of the AA
genotype in sub-Saharan Africa was reported (0.99%).
According to HapMap the GA heterozygotes among
European populations predominate in G298A poly-
morphisms. On the other hand, the GG homozygotes,
which were found in both analysed tribes, are typical of
the Euro-Brazilians, Afro-Brazilians, Asian-Brazilians and
Amerindians (Cayapo/Yanomama) [31].
The haplotype frequency was designated on the basis of
two SNPs: T-33 C and G125A (Table 2). Duffy-negative
blood groups were identified in 83% of the Shagia and
77% of Manasir, what is consistent with the epidemiologi-
cal data which demonstrated that 70 to 80% of people in
north-eastern Sudan had Duffy-negative blood group [36].
The frequency of the obtained haplotypes (Table 2) was
compared to SNP genotypic data from HapMap Data Rel
27 and the similarity was observed between the examined
groups and the population of African ancestry in the
Southwest USA (ASW: CA = 0.81; TA = 0.07; TG = 0.12).
In the presented study, determination of Duffy genotype
and phenotype was based on the T-33 C (GATA poly-
morphism) and G125A SNPs (Table 3) [10-12,15]. Twenty
combinations of genotypes for the Shagia and Manasir
tribes were examined (Table 3). There was a statistically
significant difference in frequency of one of the genotype
combinations, i.e. CC/AA/GG/CT (FY*B
ES/FY*B
ES)( p =
0.001) which occurred in 45.87% of the Shagia tribe but in
only 6.59% of the Manasir tribe.
For homozygotes with the inactive-GATA site and
G125A genotypes: FY*B/FY*B or FY*A/FY*B, the deduced
genotypes were FY*B
ES/FY*BES and FY*A
ES/FY*B
ES,
respectively and the phenotype was Fy(a-, b-).
The genotype and phenotype were consistent with
G125A when the individuals were wild-type GATA site
homozygous. According to Woolley et al [37] and Yazdan-
bakhsh et al [10], the mutation in the GATA box is asso-
ciated with the functional allele FY*B [10,37]. However,
Zimmerman et al [ 1 5 ]s u g g e s tt h a tt h eT - 3 3Cp o l y -
morphism affect Fy expression on the FY*A and FY*B
alleles in a similar manner [15]. Therefore, in the case
when an individual was characterized by heterozygous
GATA site (GATA+/-) and the genotype FY*A/FY*B (for
G125A), both types of genotypes, i.e. FY*A
ES/FY*B or
FY*A/FY*B
ES (phenotype Fy(a+, b-) or Fy(a-, b+)) can be
predicted. Similarly, for FY*A/FY*A homozygous, two
deduced genotypes such as FY*A
ES/FY*A or FY*A/FY*A
ES
(phenotype Fy(a+, b-)) were assigned. Moreover, Zimmer-
man et al [15] imply that the FY*A
ES allele is a new allele
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ES
alleles predominating in African and African-American
populations. The FY*B
ES allele was also the most numerous
identified in the Shagia 51 (+/- 2.5) and in the Manarsir
32.5 (+/- 4).
The most remarkable finding in the presented study is
the identification of occurrence of FY*A
ES allele in the ana-
lysed tribes, which is consistent with the anthropological
data and may suggest free flow of the genetic material in
the analysed populations, i.e. admixture of non-African
population in some periods. The presence of individuals
with the FY*A/FY*A genotype in the Shagia tribe, who are
not found in the Manasir population (Table 3), indicates
more numerous re-combinations among the Shagia than
the Manasir people. Interestingly, admixture of non-Afri-
can population in this geographically isolated tribe was
additionally confirmed by the authors in previous studies
[38]. Furthermore, the genetic structure of the Shagia
population differs significantly from the Manasir popula-
tion, where there was a free flow of genetic material as the
Manasir tribe inhabits the region of the Fourth Nile
Cataract with other populations such as the Beniamer,
Ababda, Foraui and Kesinger tribes. It is worth noting that
the FY*A
ES allele is not observed in a more ethnically
diverse populations, for example, in some tribes from
Papua New Guinea (i.e. South Wosera) [15].
Indigenous Africans are characterized by high levels of
genetic diversity within and between populations [26].
Also, the mtDNA evidence has suggested that southern
Africa and the remainder of sub-Saharan Africa were
regionally differentiated [39]. It would be interesting to
continue research using more powerful bio-markers,
such as Y-chromosome and/or mtDNA. Unfortunately,
both the nature of the research conducted by this study
and the small amount and unique character of the col-
lected material make it impossible.
Conclusion
The present study demonstrated, by all accounts for the
first time, Duffy-negative genotype combination i.e.
FY*B
ES/FY*A
ES. Moreover, the results suggest the admix-
ture of non-African genetic materials in both tribes.
Table 1 Allele and genotype association results for Duffy in the Shagia and Manassir
SNP Allele/genotype Allele frequency OR (95% CI) Fisher’s Exact
P-Value
Hardy-Weinberg’s Exact
P-Value
Shagia, n (%) Manasir, n (%) Shagia Manasir
T-33C T/C 33/219 (13.1/86,9) 40/142 (22/78) 0.53 (0.32-0.,88) 0.02
TT 4 (3.2) 6 (6.6) 0.01 0.22 0.36
TC 25 (19.8) 28 (30.8)
CC 97 (77) 57 (62.6)
G125A G/A 235/17 (93,2/6,8) 169/13 (92.9/7.1) 1.06 (0.5-2.25) > 0.9
GG 3 (2.4) 1 (1.1) 0.58 0.01 0.37
GA 11 (8.7) 11 (12.1)
AA 112 (88.9) 79 (86.8)
G298A G/A 162/90(64,3/35,7) 101/81 (55.5/44.5) 1.44 (0.97-2.13) 0.07
GG 36 (28.6) 10 (11) 0.002 < 0.00 < 0.00
GA 90 (71.4) 81 (89)
AA 0 (0) 0 (0)
C5411T C/T 136/116 (54/46) 95/87 (52.2/47.8) 1.07 (0.73-1.57) 0.8
CC 10 (7.9) 4 (4.4) 0.46 < 0.00 < 0.00
CT 116 (92.1) 87 (95.6)
TT 0 (0) 0 (0)
Table 2 Two-locus (T-33 C, G125A) haplotype analysis using HAPLO.SCORE, overall p = 0,08
Haplotype Haplotype frequency Overall haplotype frequency HAP-Score Overall
P-Value
Shagia Monassir
CA 0,83 0,77 0,80 -1,59 0,11
CG 0,04 0,01 0,03 -1,26 0,21
TG 0,29 0,06 0,04 1,36 0,17
TA 0,10 0,16 0,13 1,85 0,06
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with the collected ethnographic data, while with regard
to the isolated Shagia tribe, which has not been anthro-
pologically and genetically des c r i b e ds of a r ,i ti sau s e f u l
trace for explaining the history of this population. The
FY*A
ES allele, identified in both tribes, is not likely to be
directly related to the exposure of a human genome to P.
vivax but rather may be a consequence of admixture of
the non-African genetic background.
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